Sharika Enterprises Limited allotted 1,21,92,125 equity shares on a preferential basis to non-promoter entities, raising ₹17.47 crore in fresh capital. The allotment was approved by the Board of Directors on September 25, 2026.

The company also issued 28,12,315 warrants convertible into equity shares at the same price of ₹14.33 per share. This warrant issue aggregates to ₹4.03 crore, with an upfront subscription amount of ₹1.00 crore received from six allottees, including promoters and non-promoters.

Equity Share Allotment Details

The equity shares were issued at a price of ₹14.33 per share, comprising a face value of ₹5 and a premium of ₹9.33. These shares rank pari passu with existing equity shares and are subject to lock-in periods as per SEBI (ICDR) Regulations, 2018. The allotment follows member approval via special resolution on July 17, 2026, and in-principal approval from BSE on September 10, 2026.

Key institutional investors included Veloce Opportunities Fund II, Veloce Innovations LLP, and Bridge India Fund, which together accounted for a significant portion of the subscribed capital. The total consideration for the equity tranche stood at ₹17,47,13,151.

Warrant Issuance Structure

The warrants were issued at the same issue price of ₹14.33, with 25% payable upfront as a subscription price of ₹3.5825 per warrant. The remaining 75%, or ₹10.7475 per warrant, is payable upon exercise within 18 months from the date of allotment. Failure to exercise within this period results in forfeiture of the upfront payment.

What the Numbers Show

The preferential allotment introduces significant dilution potential through the convertible warrants. While the immediate cash inflow from warrants is limited to ₹1.00 crore, the full conversion would bring an additional ₹3.02 crore into the company’s coffers over the next 18 months. The concentration of equity allotment among a few major funds suggests a targeted capital raise rather than a broad-based public offering.

Sharika Enterprises received in-principle approval from the Bombay Stock Exchange on September 10, 2026, for a preferential allotment of equity shares and warrants. The exchange sanctioned the issuance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Deal Structure

The company plans to allot 1,51,49,079 equity shares of face value ₹5 each to non-promoters. These shares will be issued at a price not less than ₹14.33 each. Additionally, the firm will issue 38,38,102 warrants, convertible into an equal number of equity shares, to both promoters and non-promoters at the same minimum price of ₹14.33 each.

Regulatory Compliance

BSE advised Sharika Enterprises to strengthen internal controls to monitor trades by proposed allottees before the allotment date. The company must obtain undertakings confirming that allottees will not engage in intra-day trading or sell the scrip until the allotment date, as per Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

The exchange noted that any non-compliance could impact the listing of these shares. Sharika Enterprises must submit a listing application within twenty days of allotment, in line with Regulation 14 of the LODR Regulations and recent SEBI circulars. Failure to comply may attract fines.

What the Numbers Show

The issuance combines equity and warrant instruments, allowing promoters and non-promoters to participate in the warrant tranche while restricting the direct equity allotment to non-promoters. This structure suggests a strategic approach to capital raising that balances immediate equity infusion with deferred conversion options for existing stakeholders.